Institutional Career Development Core

机构职业发展核心

• 批准号: 10116524
• 负责人: MAUREEN A MURTAUGH
• 金额: $ 89.98万
• 依托单位: UNIVERSITY OF UTAH
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-03-30 至 2023-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10116524
• 关键词: Award; Birth; Clinical Sciences; Community Outreach; Development Plans; Ecosystem; Faculty; Foundations; Funding; Health; Healthcare; Individual; Infrastructure; Institution; K-Series Research Career Programs; Link; Manuscripts; Medicine; Mentored Research Scientist Development Award; Mentors; Principal Investigator; Productivity; Publishing; Research; Research Personnel; Resources; Scientist; Training; Translational Research; United States National Institutes of Health; Universities; Utah; career development; design; end of life; experience; improved; indexing; member; model development; pre-doctoral; programs; recruit; success

Since its inception in 2008, the Utah CCTS KL2 Program rationale has been to distinguish itself by providing promising junior faculty researchers with multidimensional mentored research experiences that enable them to develop, demonstrate, and disseminate translational science to advance health. The program draws scholars from the large pool of candidates in the seven Utah CCTS partnering institutions and provides a path to research success. The end result is the creation of a diverse team of scientists who impact local and national healthcare priorities from birth to end of life. Program impact is demonstrated by research productivity where 67% of past scholars have received additional career development awards and collectively have published 317 manuscripts with 7,094 citations (average H-index = 9.8). The objective of the Utah KL2 program for the next five years is to have promising junior faculty members achieve research success. While the typical determinant of research success is attainment of R01 level NIH support, we broaden the definition of K to Research success to include leading a scientific research enterprise of >$200,000 in annual support and conducting research with substantial impact on health and healthcare. We will realize this objective with the following three aims: Aim 1: Improve the proportion of KL2 scholars who achieve “K to R equivalent Success”, including increasing the proportion (from 17% to 50%) who are the PI on an R01 equivalent award within 5 years of completing their mentored training award. Aim 2 Increase the number of Utah CCTS KL2 Scholars who are underrepresented in medicine (URM). Aim 3: Proactively strengthen and expand use of existing clinical and translational science career development opportunities within the Utah CCTS ecosystem and the national CTSA network. Key program design features include the University’s Vice President’s Clinical and Translational science (VPCAT) program. This two year intensive experience provides the curricular and mentoring foundation for KL2 scholars by using the holistic Matrix Mentoring Model, development of an Individual Development Plans (IDP), and training in Management Essentials for Principal Investigators©. We will build on these features to accomplish our stated aims by 1) creating an institutional infrastructure specifically designed to support new investigators in pursuit of R01s, 2) implementing targeted recruitment of those underrepresented in medicine beginning at the pre-doctoral level, and 3) expand use of Utah CCTS community outreach resources and augment links with other CTSA programs. The Utah KL2 directors, Steering Committee, and established External Advisory Board will provide guidance for the program as it expands from two to four NCATS supported scholars, with a focus on increasing the diversity of the group. In addition, we will also add the option for a third year of support for scholars for whom the additional funding would be transformative.

自2008年成立以来，犹他州CCTS KL2计划的理由是通过提供来区分自己 具有多维修养研究经验的有前途的初级教师研究人员，使他们能够 发展，演示和传播转化科学以促进健康。该计划吸引了学者 从七个犹他州CCTS合作机构的大量候选人中 研究成功。最终结果是建立了一支由科学家组成的潜水团队，他们影响了地方和国家 从出生到生命尽头的医疗保健优先事项。研究生产力证明了计划的影响 过去有67％的学者获得了额外的职业发展奖，并共同出版了317 引用7,094次的手稿（平均H-index = 9.8）。 接下来五年的犹他州KL2计划的目标是承诺初级教师 取得研究成功。虽然典型的研究成功确定的是达到R01 NIH级别的支持，我们扩大了K的定义，以研究成功，包括领导科学 研究企业的年度支持> 200,000美元，并进行重大影响的研究 关于健康和医疗保健。我们将以以下三个目标实现这一目标： 目标1：提高取得“ K到等效成功”的KL2学者的比例，包括 将比例（从17％增加到50％）是R01等效奖励的PI。 完成他们的指导培训奖。 AIM 2增加了医学人数不足（URM）的犹他州CCTS KL2学者的数量。 目标3：积极强大并扩大现有临床和翻译科学生涯的使用 犹他州CCTS生态系统和国家CTSA网络中的开发机会。 关键计划设计功能包括大学副校长的临床和翻译科学 （VPCAT）程序。这两年的密集体验为课程和心理基础提供了 KL2学者通过使用整体矩阵指导模型，制定个人发展计划 （IDP），以及主要研究人员的管理必需品培训©。我们将以这些功能为基础 完成我们的陈述目标1）创建专门旨在支持新的机构基础架构 追求R01的调查人员，2）实施针对医学人数不足的人的目标招募 从博士前的层面开始，3）扩大使用犹他州CCTS社区外展资源的使用和 增强与其他CTSA程序的链接。犹他州KL2董事，指导委员会成立 外部咨询委员会将为该计划提供指导 支持学者，重点是增加小组的多样性。此外，我们还将添加 为学者提供支持的第三年支持的选择，这些学者将为额外的资金带来变革。